Medical Articles

Remibrutinib

Bruton's tyrosine kinase inhibitor (BTK inhibitor)

Description

Next-generation oral BTK inhibitor for autoimmune blistering diseases. Rapid onset with favorable safety profile vs 1st generation BTK inhibitors.

Mechanism of action

Covalent irreversible binding to BTK cysteine 481 prevents B-cell receptor signaling, inhibiting autoreactive B-cell activation and autoantibody production in pemphigus.

This page is restricted. Please Login / Register to view this page.

Mechanism of action

Covalent irreversible binding to BTK cysteine 481 prevents B-cell receptor signaling, inhibiting autoreactive B-cell activation and autoantibody production in pemphigus.

This page is restricted. Please Login / Register to view this page.